Cyclooxygenase-2 expression in colorectal cancer liver metastases

Clinical and Experimental Metastasis

Volumn 18, Issue 1, 2000, Pages 21-27

  Hull, Mark A ^a   Fenwick, Stephen W ^b   Chapple, Keith S ^a   Scott, N ^c   Toogood, Giles J ^b   Lodge, J Peter ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Hepatobiliary Unit   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Immunohistochemistry; Liver resection; Metastasis

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; ENZYME INHIBITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER METASTASIS; LIVER RESECTION; MALE; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECURRENCE;

EID: 0035135894     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026553605636     Document Type: Article

References (32)

1. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
2. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
3. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer
4. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats
5. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
6. Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps
7. The role of COX-2 in intestinal cancer
8. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
9. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
10. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
11. The relationship between cyclooxygenase-2 expression and colorectal cancer
12. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs and colon cancer
13. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)
14. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2
15. Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors
16. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
17. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
18. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment
19. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases
20. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system
21. Resection of colorectal liver metastases
22. Current treatment for colorectal cancer metastatic to the liver
23. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
24. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)- selective non-steroidal anti-inflammatory drug: Independence from COX-2 protein expression
25. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
26. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
27. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
28. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors
29. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
30. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
31. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
32. Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells. Involvement of cyclooxygenase-2